Did you know that 300 million people, 5% of the world’s population, live with a rare disease?
Today is Rare Disease Day. Check out the Hebrew University’s innovative research and connect with us for potential Research Options and Licensing opportunities to advance treatments, diagnostics and novel medications, helping those sufffering around the world.
✔ Prof. Rotem Karni leads RNABLE, a novel target for the treatment of rare genetic diseases and cancer caused by nonsense mutations
✔ Prof. Rami Aqeilan developed a promising treatment for WWOX associated neurological disorders
✔ Prof. Yuval Tabach created a platform for Identifying the genetic cause of inherited diseases used for discovering targeted personalized therapies
✔ Prof. Haya Lorberboum-Galski Novel developed a treatment of mitochondrial disorders using enzyme replacement therapy
✔ Dr. Haitham Amal developed a new treatment for #autism spectrum disorder
✔ Prof. Meir Bialer leads the research on SPD, a new drug for status epileptics and other CNS disorders
✔ Prof. Nissim Benvenisty has patented a drug therapy for imprinting disorders based on genetic screening
✔ Prof. Dmitry Tsevlikhovsky created a platform technology to synthesize natural compounds for the treatment of neurological conditions and other disorders